Dr. Susan C. Stansfield has been appointed executive vice president, with responsibility for product registration activities in Europe, Africa and Asia-Pacific for PRA International. David Dockhorn, executive vice president, will continue to have responsibility for product registration activities for the Americas.

“We are very pleased to continue the process of strengthening our management team with the addition of Dr. Stansfield,” said Terrance J. Bieker, chief executive officer of PRA International. “The appointment of an executive dedicated to Product Registration activities in Europe, Africa and Asia-Pacific reflects the growing scale of our international operations and the additional opportunities we have to continue growing this part of our business. Dr. Stansfield has built an exceptional track record for managing world-class clinical research organizations and delivering results. Dr. Stansfield shares the client-centric focus that is a core value of PRA, and we believe she is well suited to take our international operations to the next level.”

Dr. Stansfield has more than 20 years of experience in the clinical research industry. She joins the company from Pharmaceutical Product Development, Inc. (PPD), where she most recently served as senior vice president, project management and clinical operations, Europe. Under her management, the European operations achieved substantial increases in revenue, gross profit and operating margin.

Dr. Stansfield has also held senior management positions at Quintiles and Innovex, where she was responsible for business process improvement and managing full-service clinical research projects.